Home » Ian Copple – Biomarker discovery to enable the non-invasive monitoring of NRF2 activator therapies in humans
Ian Copple – University of Liverpool – Medicines Discovery Catapult – Healthcare
Biomarker discovery to enable the non-invasive monitoring of NRF2 activator therapies in humans
The RiR Sprint scheme is now closed. Thank you for your interest.